A genomic strategy for targeting therapy in castration-Independent Prostate Cancer

被引:0
|
作者
Mendiratta, P. [1 ]
Tewari, A. [1 ]
Guinney, J. [1 ]
Porrello, A. [1 ]
Barry, W. T. [1 ]
Febbo, P. G. [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
关键词
D O I
10.1200/jco.2008.26.15_suppl.5067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5067
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate Cancer
    Mendiratta, Prateek
    Mostaghel, Elahe
    Guinney, Justin
    Tewari, Alok K.
    Porrello, Alessandro
    Barry, William T.
    Nelson, Peter S.
    Febbo, Phillip G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2022 - 2029
  • [2] Targeting TCTP as a New Therapeutic Strategy in Castration-resistant Prostate Cancer
    Baylot, Virginie
    Katsogiannou, Maria
    Andrieu, Claudia
    Taieb, David
    Acunzo, Julie
    Giusiano, Sophie
    Fazli, Ladan
    Gleave, Martin
    Garrido, Carmen
    Rocchi, Palma
    [J]. MOLECULAR THERAPY, 2012, 20 (12) : 2244 - 2256
  • [3] p300 and CBP targeting in castration therapy resistant prostate cancer
    Furlan, Tobias
    Sampson, Natalie
    Santer, Frederic R.
    Culig, Zoran
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [4] Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer
    Wang, Bin
    Lo, U-Ging
    Wu, Kaijie
    Kapur, Payal
    Liu, Xiangyang
    Huang, Jun
    Chen, Wei
    Hernandez, Elizabeth
    Santoyo, John
    Ma, Shi-Hong
    Pong, Rey-Chen
    He, Dalin
    Cheng, Yi-Qiang
    Hsieh, Jer-Tsong
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (10) : 2121 - 2130
  • [5] Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy
    De Velasco, Marco A.
    Kura, Yurie
    Sakai, Kazuko
    Hatanaka, Yuji
    Davies, Barry R.
    Campbell, Hayley
    Klein, Stephanie
    Kim, Youngsoo
    MacLeod, A. Robert
    Sugimoto, Koichi
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    [J]. JCI INSIGHT, 2019, 4 (17)
  • [6] THE RATIONALE OF COMBINATION THERAPY TARGETING INTRATUMORAL STEROIDOGENESIS IN CASTRATION RESISTANT PROSTATE CANCER (CRPC)
    Hamid, Agus Rizal A. H.
    Dudek, Aleksandra
    Pfeiffer, Minja J.
    Voller, Maureen C. W.
    Verhaegh, Gerald W.
    Schalken, Jack A.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E93 - E94
  • [7] The Effect of Prostate Cancer-Targeting Doxorubicin Nanomicelles Combined with Photothermal Therapy on Castration-Resistant Prostate Cancer
    Su, Xiaohong
    Li, Chuanyin
    Xu, Kai
    Su, Wei
    Mao, Xiangming
    Zou, Yong
    Li, Bingkun
    [J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2022, 18 (05) : 1276 - 1288
  • [8] Targeting the MLL complex in castration resistant prostate cancer
    Malik, Rohit
    Khan, Amjad P.
    Asangani, Irfan A.
    Cieslik, Marcin
    Prensner, John R.
    Wang, Xiaoju
    Iyer, Matthew K.
    Jiang, Xia
    Borkin, Dmitry
    Escara-Wilke, June
    Stender, Rachel
    Wu, Yi-Mi
    Cao, Xuhong
    Feng, Felix Y.
    Grembecka, Jolanta
    Cierpicki, Tomasz
    Chinnaiyan, Arul M.
    [J]. CANCER RESEARCH, 2015, 75
  • [9] Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
    Zhong, Shangwei
    Huang, Changhao
    Chen, Zhikang
    Chen, Zihua
    Luo, Jun-Li
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [10] Targeting castration-induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model
    Johansson, Anna
    Rudolfsson, Stina Haggstrom
    Kilter, Sigrid
    Bergh, Anders
    [J]. BJU INTERNATIONAL, 2011, 107 (11) : 1818 - 1824